Regulation of Tau Pathology by the Microglial Fractalkine Receptor

Bhaskar, Kiran, Konerth, Megan, Kokiko-Cochran, Olga N., Cardona, Astrid, Ransohoff, Richard M., Lamb, Bruce T.·2010·Neuron
DOI 10.1016/j.neuron.2010.08.023

Cited by (642)

Items 601–642 of 642

  1. Protein kinase CK2α′ as a dual modulator of neuroimmune signaling and synaptic dysfunction in tauopathy
    Angel White, Peter Gavrilyuk, Persephone Gu, Rafael Falcon Moya, Robert Henry Thurston, Amal Fickak, Nicholas B Rozema, Prarthana Keshavaram, Scott Vermilyea, Riley Schlichte et al. · 2026 · Translational Neurodegeneration
  2. Mature tau pathology is not improved by interfering with interleukin-1 receptor signaling in two mouse models of tauopathy
    Dylan J. Finneran, Brianna M. Jackman, Taylor Desjarlais, Alayna Henry, Ahlam S. Soliman, Patricia C. Muskus, Rama Shankar, Bin Chen, Kevin R. Nash, David Morgan et al. · 2025 · PLoS ONE
  3. Chemokine receptor CX3CR1 modulates microglial activity through Tau and amyloid-β interactions in Alzheimer’s disease
    Vaishnavi Ananathanarayana, Riddhi Upadhyay, Gouri H. Illanad, Deena Krishnan, Neha P. Bochageri, Murugan Sevanan, Zabin Bagewadi, R. Sivasamy, Subashchandrabose Chinnathambi · 2025 · Advances in immunology
  4. Additional file 8 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  5. Additional file 11 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  6. Additional file 3 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
    Zhu, Bing, Liu, Yan, Spring Yewon Hwang, Kailey Archuleta, Huang, Huijie, Campos, Alex, Rabi Murad, Juan Piña-Crespo, Xu, Huaxi, Huang, Timothy Y. · 2022 · Figshare
  7. Additional file 6 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
    Zhu, Bing, Liu, Yan, Spring Yewon Hwang, Kailey Archuleta, Huang, Huijie, Campos, Alex, Rabi Murad, Juan Piña-Crespo, Xu, Huaxi, Huang, Timothy Y. · 2022 · Figshare
  8. Additional file 6 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  9. Additional file 5 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
    Zhu, Bing, Liu, Yan, Spring Yewon Hwang, Kailey Archuleta, Huang, Huijie, Campos, Alex, Rabi Murad, Juan Piña-Crespo, Xu, Huaxi, Timothy Y. Huang · 2022 · Figshare
  10. Additional file 4 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
    Zhu, Bing, Liu, Yan, Spring Yewon Hwang, Kailey Archuleta, Huang, Huijie, Campos, Alex, Rabi Murad, Juan Piña-Crespo, Xu, Huaxi, Huang, Timothy Y. · 2022 · Figshare
  11. Additional file 4 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, McFarland, Karen N., Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  12. Additional file 7 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
    Zhu, Bing, Liu, Yan, Spring Yewon Hwang, Kailey Archuleta, Huang, Huijie, Campos, Alex, Rabi Murad, Juan Piña-Crespo, Xu, Huaxi, Timothy Y. Huang · 2022 · Figshare
  13. Additional file 1 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, McFarland, Karen N., Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  14. Additional file 2 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Xue Wang et al. · 2022 · Figshare
  15. Additional file 1 of A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease
    Niels Prins, Harrison, John E., Chu, Hui-May, Kelly Blackburn, John J. Alam, Philip Scheltens · 2021 · Figshare
  16. Additional file 9 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  17. Additional file 2 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
    Zhu, Bing, Liu, Yan, Spring Yewon Hwang, Kailey Archuleta, Huang, Huijie, Campos, Alex, Rabi Murad, Juan Piña-Crespo, Xu, Huaxi, Huang, Timothy Y. · 2022 · Figshare
  18. Additional file 2 of A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease
    Prins, Niels D., Harrison, John E., Chu, Hui-May, Kelly Blackburn, John J. Alam, Philip Scheltens · 2021 · Figshare
  19. Additional file 3 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  20. Additional file 10 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  21. Additional file 3 of A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer’s disease
    Prins, Niels D., Harrison, John E., Chu, Hui-May, Kelly Blackburn, John J. Alam, Scheltens, Philip · 2021 · Figshare
  22. Additional file 1 of Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer’s disease
    Li, Xiao, Zhang, Deng-Feng, Bi, Rui, Tan, Li-Wen, Chen, Xiaogang, Xu, Min, Yao, Yong-Gang · 2023 · Figshare
  23. Additional file 5 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  24. Additional file 7 of Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, De La Cruz, Elsa Gonzalez, Shah, Shivani, Quan Vo, Wang, Xue et al. · 2022 · Figshare
  25. Additional file 1 of Trem2 deletion enhances tau dispersion and pathology through microglia exosomes
    Zhu, Bing, Liu, Yan, Spring Yewon Hwang, Kailey Archuleta, Huang, Huijie, Campos, Alex, Rabi Murad, Juan Piña-Crespo, Xu, Huaxi, Huang, Timothy Y. · 2022 · Figshare
  26. A Systematic Review to Evaluate the Effect of Neflamapimod on Cognitive Function and Progression of Dementia
    Satvik Tyagi, Naveen Murali, Sandeep Kumar Singh, Smruti Babtiwale, Bijaya Kumar Padhi, N R Aiswarya Lakshmi, Aravind P. Gandhi · 2026 · Neurology India
  27. Extracellular Vesicles in Tauopathies: Mechanisms and Applications
    Varun Nannuri, Ebaa Ababneh, Serena El Rayes, Jonhoi Smith, Kiminobu Sugaya, Jihe Zhao · 2026 · International Journal of Molecular Sciences
  28. Female-specific Cx3cr1-driven regulation of ALS and Alzheimer’s risk genes in tauopathy
    Ari Sudwarts, Gopal Thinakaran · 2026 · Molecular Neurodegeneration Advances
  29. Rôle de la neuroinflammation et du récepteur microglial TREM2 dans la progression de deux modèles de tauopathie
    Audrey Vautheny · 2019 · theses.fr (ABES)
  30. Étude de la composante neuroinflammatoire dans les DFT/SLA
    Julie Smeyers · 2020 · theses.fr (ABES)
  31. Impact of α-synuclein fibrillar strains and ß-amyloid assemblies on cultured mouse cortical neurons endo-lysosomal logistics
    Qiao-Ling Chou · 2021 · theses.fr (ABES)
  32. Microglia detection and phagocytosis of dying neurons is regulated by CX3CR1
    Maryanne N. Barasa, Alicia N. Pietramale, Robert Hill · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  33. A GPCR atlas across human microglial states in Alzheimer's disease: Insights from snRNA-seq and hiPSC models
    Bing Zhang, Ran Zhao, Xiao-Yan Li, Zi-Han Wei, Dong-Mei Wang, Mei-Hong Lu · 2026 · Experimental Neurology
  34. Visceral adipose tissue differentially affects tau and Aβ pathology in 3xTg-AD mice
    Laura Trujillo‐Estrada, Miriam Bettinetti‐Luque, Juana Andreo‐Lopez, Celia Da Cunha, Mario Morales‐Cabello, Cynthia Campos‐Moreno, Elisabeth Sánchez‐Mejías, Stefânia Forner, Alessandra Cadete Martini, Raquel Maria Sanchez-Varo et al. · 2026 · Cell Communication and Signaling
  35. Chronic pain in Alzheimer disease and the role of neuroimmune interactions
    Marzia Malcangio, George Sideris-Lampretsas · 2026 · Pharmacological Reviews
  36. Mechanisms of autophagy–lysosome pathway impairment in Alzheimer's disease
    Kun Lü, Yirui Lu, Runyu Tang, Xiaofeng Dong, Pingping Zhuang, Yu Gao, Min Cheng, Yi Wang, Yubing Wang · 2026 · Journal of Alzheimer s Disease
  37. The multifaceted roles of IL-1β in Alzheimer’s disease: From pathogenic amplifier to neuroimmune modulator
    Dominika Piłat, Kévin Baranger, Santiago Rivera · 2026 · Cytokine & Growth Factor Reviews
  38. CX3CR1 Modulates Migration of Resident Microglia Towards Cortical Laser‐Induced Lesions
    Jens Wagner, Henrike Antony, Cornelia Hoyer, Kristiina Lundgrén, Rabah Soliymani, Sophie Crux, Lena Christine Justus, Kevin Keppler, Julia Steffen, Christian Kurts et al. · 2026 · Glia
  39. Targeting Microglial Receptors for Alzheimer’s Disease: Translational Barriers from Bench to Bedside
    Xiaoyu Tang, Ilminur Hasan, Jianrong Xu · 2026 · Neuropharmacology and Therapy
  40. Elevated DYRK1A in Primary Tauopathies and Therapeutic Targeting with the Brain-Penetrant Inhibitor DYR533
    Ramón Velázquez, Samantha K. Bartholomew, Wendy Winslow, Savannah Tallino, Christopher Foley, Yeng Shaw, Samantha Rokey, Jessica M. Judd, Thomas Beach, Geidy E. Serrano et al. · 2026 · Research Square
  41. When Pathologies Collide: The Intersection of Tau and Alpha-Synuclein in Neurodegenerative Diseases
    Jenna N. Hunt, Sandhya Kortagere · 2026 · Molecular Neurobiology
  42. Comparative Analysis of Plasma Biomarkers of Alzheimer’s Disease and Frontotemporal Dementia: The Dual Role of Soluble Fractalkine as a Biomarker of Frontotemporal Dementia and Its Neuroprotective Effects in Cortical Neurons “In Vitro”
    Jose Joaquín Merino, Jose Julio Rodriguez, Xavier Busquets, Ana Isabel Flores, A. Tolédano · 2026 · Life